plutonium has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloyd, RD; Miller, SC; Taylor, GN | 1 |
| Oghiso, Y; Yamada, Y | 1 |
2 other study(ies) available for plutonium and Hematologic Malignancies
| Article | Year |
|---|---|
Does malignant hematopoietic disease result from internal exposure to 239Pu?
Topics: Age Distribution; Animals; Body Burden; Disease Models, Animal; Dogs; Female; Hematologic Neoplasms; Incidence; Injections; Leukemia, Radiation-Induced; Male; Models, Biological; Plutonium; Radiation Dosage; Radiometry; Reference Values; Risk Assessment; Survival Analysis; Survival Rate | 2004 |
Strain differences in carcinogenic and hematopoietic responses of mice after injection of plutonium citrate.
Topics: Alpha Particles; Animals; Animals, Outbred Strains; Bone Marrow Cells; Bone Neoplasms; Cell Count; Cell Lineage; Citric Acid; Colony-Forming Units Assay; Crosses, Genetic; Female; Hematologic Neoplasms; Hematopoiesis; Injections, Intraperitoneal; Leukemia, Radiation-Induced; Leukocyte Count; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Species Specificity; Specific Pathogen-Free Organisms; Spleen; Thymus Neoplasms | 2000 |